Agenus Inc - Oct 13, 2021 Form 3 Insider Report for MiNK Therapeutics, Inc. (INKT)

Role: 10%+ Owner
Signature: /s/ Christine Klaskin, Vice President, Finance
Stock symbol: INKT
Transactions as of: Oct 13, 2021
Transactions value $: $0
Form type: 3
Date filed: 10/20/2021, 07:02 PM
Next filing: Oct 20, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	INKT	Common Stock						19.5M	Oct 13, 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	INKT	Convertible Promissory Note							Oct 13, 2021	Common Stock	5.45M		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The convertible promissory note has a maturity date of July 1, 2022, and will be automatically converted into common stock upon completion of the IPO at a rate equal to the quotient obtained by dividing (i) the amount due on the date of conversion by (ii) 80% of the per share price of the common stock sold in the IPO.